Cancer Incidence and Mortality among Blacks, New York State Excl New York City, 2015-2019
Source: New York State Cancer Registry
| Site of Cancer | Incidence | Mortality | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Males and Females | Males | Females | Males and Females | Males | Females | |||||||||||||
| Average Annual Cases | Rate per 100,000 Population | 95% CI | Average Annual Cases | Rate per 100,000 Males | 95% CI | Average Annual Cases | Rate per 100,000 Females | 95% CI | Average Annual Deaths | Rate per 100,000 Population | 95% CI | Average Annual Deaths | Rate per 100,000 Males | 95% CI | Average Annual Deaths | Rate per 100,000 Females | 95% CI | |
| All Invasive Malignant Tumors | 5231.8 | 479.3 | 473.4-485.3 | 2694.8 | 564.1 | 554.1-574.3 | 2537.0 | 422.0 | 414.6-429.6 | 1551.4 | 151.2 | 147.8-154.7 | 769.8 | 182.6 | 176.5-188.8 | 781.6 | 131.4 | 127.2-135.6 |
| Oral cavity and pharynx | 89.8 | 8.0 | 7.3-8.8 | 61.2 | 12.3 | 10.9-13.8 | 28.6 | 4.8 | 4.0-5.6 | 21.4 | 2.0 | 1.6-2.4 | 16.0 | 3.4 | 2.7-4.3 | 5.4 | 0.9 | 0.6-1.3 |
| Esophagus | 42.8 | 4.1 | 3.6-4.7 | 27.6 | 6.4 | 5.4-7.7 | 15.2 | 2.5 | 2.0-3.1 | 29.4 | 2.8 | 2.4-3.4 | 21.6 | 5.2 | 4.2-6.3 | 7.8 | 1.2 | 0.9-1.7 |
| Stomach | 120.0 | 11.7 | 10.8-12.7 | 63.4 | 14.3 | 12.7-16.0 | 56.6 | 9.9 | 8.7-11.1 | 47.6 | 4.7 | 4.1-5.3 | 29.2 | 6.9 | 5.8-8.2 | 18.4 | 3.1 | 2.5-3.8 |
| Colorectal | 438.4 | 40.8 | 39.0-42.6 | 223.6 | 48.2 | 45.3-51.3 | 214.8 | 35.6 | 33.5-37.8 | 143.2 | 14.0 | 12.9-15.1 | 73.8 | 17.1 | 15.3-19.0 | 69.4 | 11.7 | 10.5-13.0 |
| Colon excluding rectum | 316.2 | 29.8 | 28.3-31.3 | 154.2 | 34.0 | 31.5-36.6 | 162.0 | 27.0 | 25.1-28.9 | 118.8 | 11.6 | 10.6-12.6 | 61.6 | 14.3 | 12.7-16.1 | 57.2 | 9.6 | 8.5-10.8 |
| Rectum & rectosigmoid | 122.2 | 11.0 | 10.1-11.9 | 69.4 | 14.2 | 12.7-15.9 | 52.8 | 8.6 | 7.6-9.8 | 24.4 | 2.4 | 2.0-2.9 | 12.2 | 2.8 | 2.1-3.6 | 12.2 | 2.1 | 1.6-2.7 |
| Liver / intrahepatic bile duct | 126.6 | 10.8 | 10.0-11.7 | 91.4 | 17.7 | 16.1-19.5 | 35.2 | 5.5 | 4.7-6.4 | 84.8 | 7.7 | 6.9-8.5 | 58.6 | 12.0 | 10.6-13.5 | 26.2 | 4.4 | 3.6-5.2 |
| Pancreas | 177.8 | 17.1 | 15.9-18.3 | 80.2 | 17.6 | 15.9-19.6 | 97.6 | 16.5 | 15.0-18.0 | 129.4 | 12.7 | 11.7-13.7 | 61.2 | 13.8 | 12.2-15.5 | 68.2 | 11.7 | 10.5-13.0 |
| Larynx | 36.8 | 3.3 | 2.8-3.8 | 29.4 | 6.1 | 5.1-7.2 | 7.4 | 1.1 | 0.8-1.6 | 12.0 | 1.1 | 0.8-1.4 | 9.6 | 2.2 | 1.6-2.9 | 2.4 | 0.4 | 0.2-0.7 |
| Lung and bronchus | 604.8 | 57.1 | 55.0-59.2 | 319.2 | 72.5 | 68.8-76.3 | 285.6 | 46.8 | 44.4-49.3 | 336.4 | 32.6 | 31.0-34.2 | 185.6 | 44.1 | 41.2-47.2 | 150.8 | 25.0 | 23.2-26.8 |
| Melanoma of the skin | 10.8 | 1.0 | 0.8-1.4 | 4.8 | 1.0 | 0.6-1.6 | 6.0 | 1.0 | 0.7-1.5 | 2.4 | 0.2 | 0.1-0.4 | 1.6 | 0.4 | 0.2-0.7 | 0.8 | 0.1 | 0.0-0.4 |
| Female breast | 785.6 | 131.1 | 127.0-135.4 | 136.0 | 22.6 | 20.9-24.4 | ||||||||||||
| Cervix uteri | 46.6 | 7.8 | 6.8-8.9 | 15.2 | 2.6 | 2.0-3.2 | ||||||||||||
| Corpus uterus and NOS | 187.6 | 30.2 | 28.3-32.3 | 51.6 | 8.6 | 7.5-9.7 | ||||||||||||
| Ovary | 50.0 | 8.3 | 7.3-9.4 | 29.6 | 5.0 | 4.2-5.9 | ||||||||||||
| Prostate | 1037.2 | 206.9 | 201.1-212.9 | 98.4 | 27.6 | 25.1-30.2 | ||||||||||||
| Testis | 9.4 | 1.6 | 1.2-2.1 | 0.0 | 0.0 | 0.0-0.2 | ||||||||||||
| Urinary bladder (incl. in situ) | 133.8 | 13.1 | 12.1-14.2 | 90.8 | 21.3 | 19.3-23.5 | 43.0 | 7.4 | 6.4-8.5 | 24.8 | 2.6 | 2.2-3.2 | 14.6 | 4.1 | 3.2-5.2 | 10.2 | 1.8 | 1.3-2.3 |
| Kidney and renal pelvis | 216.8 | 19.6 | 18.4-20.8 | 135.6 | 27.2 | 25.0-29.4 | 81.2 | 13.6 | 12.2-15.0 | 28.2 | 2.7 | 2.3-3.2 | 18.6 | 4.1 | 3.2-5.0 | 9.6 | 1.7 | 1.2-2.3 |
| Brain and other central nervous system | 45.4 | 4.0 | 3.5-4.6 | 24.2 | 4.7 | 3.9-5.7 | 21.2 | 3.5 | 2.9-4.3 | 25.4 | 2.3 | 1.9-2.7 | 12.0 | 2.3 | 1.8-3.0 | 13.4 | 2.2 | 1.7-2.8 |
| Thyroid | 126.0 | 11.2 | 10.4-12.2 | 27.6 | 5.6 | 4.7-6.6 | 98.4 | 16.6 | 15.1-18.2 | 5.8 | 0.6 | 0.4-0.8 | 2.8 | 0.7 | 0.4-1.2 | 3.0 | 0.5 | 0.3-0.8 |
| Hodgkin lymphoma | 34.6 | 3.0 | 2.6-3.5 | 17.8 | 3.2 | 2.6-4.0 | 16.8 | 2.8 | 2.2-3.5 | 2.6 | 0.2 | 0.1-0.4 | 2.2 | 0.5 | 0.2-0.9 | 0.4 | 0.1 | 0.0-0.3 |
| Non-Hodgkin lymphomas | 175.2 | 16.1 | 15.0-17.2 | 95.4 | 19.8 | 18.0-21.8 | 79.8 | 13.3 | 12.0-14.7 | 41.6 | 4.0 | 3.4-4.6 | 25.0 | 5.7 | 4.7-6.9 | 16.6 | 2.8 | 2.2-3.5 |
| Myeloma | 162.6 | 15.3 | 14.3-16.4 | 83.6 | 18.5 | 16.7-20.5 | 79.0 | 13.1 | 11.8-14.5 | 49.4 | 5.0 | 4.4-5.7 | 25.2 | 6.3 | 5.2-7.6 | 24.2 | 4.2 | 3.5-5.0 |
| Leukemias | 120.4 | 11.2 | 10.3-12.1 | 64.6 | 13.9 | 12.3-15.6 | 55.8 | 9.3 | 8.2-10.5 | 49.8 | 4.9 | 4.3-5.5 | 26.0 | 6.2 | 5.1-7.5 | 23.8 | 4.0 | 3.3-4.8 |
Notes
- Incidence data are provisional, November 2021.
- Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
- Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.
- NYSCR mortality statistics might differ slightly from official mortality statistics due to the availability of additional demographic information.
